Biggest News Aggregation in the World
📰 Ivir News

Page 10 - Ivir News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ivir. Real-time updates on events, politics, business and more.

Vir Biotechnology, Inc. (NASDAQ:VIR) Major Shareholder Sells $2,326,102.38 in Stock

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 91,651 shares of Vir Biotechnology stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $25.38, for a total value of $2,326,102.38. Following the completion of the sale, the insider now owns […]
Third Bancorp Jpmorgan Chase Co Morgan Stanley Tucker Asset Management Endurance Cayman Ltd Svf Vir Biotechnology Company Profile

Viridium Pacific Group (CVE:VIR) Stock Price Up 5.6%

Shares of Viridium Pacific Group Ltd (CVE:VIR – Get Rating) rose 5.6% during trading on Friday . The stock traded as high as C$0.41 and last traded at C$0.38. Approximately 26,500 shares were traded during trading, a decline of 71% from the average daily volume of 92,632 shares. The stock had previously closed at C$0.36. […]
Viridium Pacific Group Viridium Pacific Group Price Performance Viridium Pacific Group Company Profile News Ratings For Viridium Pacific Group Daily Viridium Pacific Group Ltd Get Rating

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Vir Biotechnology, Inc. (NASDAQ:VIR) Major Shareholder Endurance (Cayman) Ltd Svf Sells 83,674 Shares

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 83,674 shares of the stock in a transaction that occurred on Wednesday, May 3rd. The shares were sold at an average price of $25.51, for a total transaction of $2,134,523.74. Following the sale, the insider now directly owns 17,751,051 shares of […]
Securities Exchange Commission Vir Biotechnology Company Profile Vir Biotechnology Inc Endurance Cayman Ltd Svf Dimensional Fund Advisors Morgan Stanley

Vir Biotechnology (NASDAQ:VIR) Issues Quarterly Earnings Results, Misses Expectations By $0.20 EPS

Vir Biotechnology (NASDAQ:VIR – Get Rating) posted its quarterly earnings results on Thursday. The company reported ($1.06) EPS for the quarter, missing the consensus estimate of ($0.86) by ($0.20), Briefing.com reports. The business had revenue of $63.00 million for the quarter, compared to analyst estimates of $50.10 million. The firm’s quarterly revenue was down 94.9% […]
Annm Hanly Vir Biotechnology Company Profile Needham Company Securities Exchange Commission Endurance Cayman Ltd Svf Blackrock Inc

Vir Biotechnology (NASDAQ:VIR) Releases Earnings Results, Misses Expectations By $0.20 EPS

Vir Biotechnology (NASDAQ:VIR – Get Rating) announced its quarterly earnings data on Thursday. The company reported ($1.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.86) by ($0.20), Briefing.com reports. The company had revenue of $63.00 million for the quarter, compared to analyst estimates of $50.10 million. During the same period in […]
Vir Biotechnology Company Profile Goldman Sachs Group Morgan Stanley Vir Biotechnology Inc Blackrock Inc Vanguard Group Inc
Source: wkrb13.com

Insider Selling: Vir Biotechnology, Inc. (NASDAQ:VIR) Major Shareholder Sells 305,393 Shares of Stock

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Rating) major shareholder Endurance (Cayman) Ltd Svf sold 305,393 shares of the firm’s stock in a transaction on Friday, April 21st. The shares were sold at an average price of $25.78, for a total value of $7,873,031.54. Following the sale, the insider now directly owns 17,904,799 shares of the […]
Blackrock Inc Renaissance Technologies Vir Biotechnology Inc Morgan Stanley Vir Biotechnology Company Profile Endurance Cayman Ltd Svf

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science